Mithun Abraham Prakash (@mithunap11) 's Twitter Profile
Mithun Abraham Prakash

@mithunap11

Assistant Professor, Clinical Haematology, CMC Vellore

ID: 1534931212258934784

calendar_today09-06-2022 16:11:55

216 Tweet

470 Followers

789 Following

Jayastu Senapati (@jayastumd) 's Twitter Profile Photo

➡️ Check out our manuscript just published in AmericanJournalofHematology on Treated Secondary-AML: 673 patients, largest reported cohort 🔴 High-risk subtype: outcomes dismal, even in rare patients with fav genomics ✅ Warrants an independent prognostic designation 🔵 Ven improves outcomes in

➡️ Check out our manuscript just published in <a href="/AjHematology/">AmericanJournalofHematology</a> on Treated Secondary-AML: 673 patients, largest reported cohort
🔴 High-risk subtype: outcomes dismal, even in rare patients with fav genomics ✅ Warrants an independent prognostic designation
🔵 Ven improves outcomes in
Trey Kinsey (@haledwardkinsey) 's Twitter Profile Photo

Recently traveled to DC to donate stem cells through NMDP. This is the most direct and least invasive way to save a life for someone with cancer. Please consider joining the registry!

Recently traveled to DC to donate stem cells through <a href="/nmdp_org/">NMDP</a>. This is the most direct and least invasive way to save a life for someone with cancer. Please consider joining the registry!
akhilrk1989 (@akhilrk1989) 's Twitter Profile Photo

🚨Thrilled to share our Burkitt lymphoma/leukemia study in Blood Cancer Journal. Massive effort(n=265) from Hematology Cancer Consortium. MTX & EPOCH protocols equally effective overall, but MTX outperforms in CSF+ & BM+ cases. Valuable insights for treatment decisions! nature.com/articles/s4140…

🚨Thrilled to share our Burkitt lymphoma/leukemia study in <a href="/BloodCancerJnl/">Blood Cancer Journal</a>. Massive effort(n=265) from <a href="/HCC_HemeCancer/">Hematology Cancer Consortium</a>. MTX &amp; EPOCH protocols equally effective overall, but MTX outperforms in CSF+ &amp; BM+ cases. Valuable insights for treatment decisions! nature.com/articles/s4140…
Arun Kumar Arunachalam (@draruncmc) 's Twitter Profile Photo

Super excited to share the results of our phase I decentralised manufacturing CAR T trial (VELCART) in B-ALL and DLBCL patients at CMC Vellore (Official). Excited for the phase II 😊 Hamenth Vikram Mathews Uday Kulkarni cell.com/molecular-ther…

Hematology Cancer Consortium (@hcc_hemecancer) 's Twitter Profile Photo

🧵👇Are you a clinician, researcher, or policymaker in hematological cancers? Then you should know about HCC. ➡️We’re a multi-center academic group powered by India’s top cancer institutions. ➡️Our mission? Build credible region-specific data that transforms care in blood cancers

🧵👇Are you a clinician, researcher, or policymaker in hematological cancers?
Then you should know about HCC.
➡️We’re a multi-center academic group powered by India’s top cancer institutions.
➡️Our mission? Build credible region-specific data that transforms care in blood cancers
Vikram Mathews (@mathewsvikram) 's Twitter Profile Photo

Post graduate CME in hematology 2025 pgcmehematology.net August 19th to 21st 2025 Registeration is open - Department of Hematology and Department of Transfusion Medicine & Immunohematology Christian Medical College, Vellore

Lingaraj Nayak (@lingarajnayak) 's Twitter Profile Photo

🚨 CAST trial from Australia-New Zealand - A practise changing one! PTCY with CNI - A new SOC for MSD transplants. Anti-metabolites can “rest in peace”! Below is the comparisons between BMT CTN 1703, HOVON-96 and CAST study. #bmt NEJM

🚨 CAST trial from Australia-New Zealand - A practise changing one!

PTCY with CNI - A new SOC for MSD transplants. 
Anti-metabolites can “rest in peace”! 

Below is the comparisons between BMT CTN 1703, HOVON-96 and CAST study. 

#bmt <a href="/NEJM/">NEJM</a>
Charles Jiang MD, MPH (@charlesjiangmd) 's Twitter Profile Photo

Still digesting all the data from #ASCO25. Wanted to share my thoughts on a topic I found particularly fascinating: the timing of checkpoint inhibitor infusions. I'm no expert in chronobiology, but the data presented seem compelling and sparks a lot of questions.

Houssein Safa, MD (@hsafamd) 's Twitter Profile Photo

The best part of Hematology/Oncology? You build deep, meaningful relationships with your patients. The hardest part of Hematology/Oncology? You build deep, meaningful relationships with your patients.

CMC Vellore (Official) (@offcmcvellore) 's Twitter Profile Photo

CMC Vellore signs 2 MoUs with Federal Bank Hormis Memorial Foundation New #pharmacy College set to open in 2026–27 with 60 seats, funded by #HormisMemorial Foundation Cancer care support via SanjeevaniNews18FederalBank - 764 patients already aided MoU signed by Mr. KVS Manian, Managing

CMC Vellore signs 2 MoUs with Federal Bank Hormis Memorial Foundation
New #pharmacy  College set to open in 2026–27 with 60 seats, funded by #HormisMemorial Foundation
Cancer care support via <a href="/Sanjeevani_Nw18/">SanjeevaniNews18FederalBank</a> - 764 patients already aided
MoU signed by Mr. KVS Manian, Managing
Hematology Cancer Consortium (@hcc_hemecancer) 's Twitter Profile Photo

🇮🇳 India is uniting to revolutionize blood cancer care. Join the movement at the 5th Annual Meeting of #HCCIndia, Oct 3–5, 2025 at NCI-AIIMS, Jhajjar. 🧬 A landmark platform driving collaborative, patient-centered clinical trials across leukemias, lymphomas, and AML.

🇮🇳 India is uniting to revolutionize blood cancer care.
Join the movement at the 5th Annual Meeting of #HCCIndia, Oct 3–5, 2025 at NCI-AIIMS, Jhajjar.
🧬 A landmark platform driving collaborative, patient-centered clinical trials across leukemias, lymphomas, and AML.
Charanpreet Singh (@charanpreet_14) 's Twitter Profile Photo

Excited to share our latest publication highlighting the use of a fixed, low dose of Nivolumab in patients with R/R Hodgkin Lymphoma #lymsm link.springer.com/article/10.100… Grateful to Gaurav Prakash M.D. and Pankaj Malhotra for the mentorship

Vikram Mathews (@mathewsvikram) 's Twitter Profile Photo

Who Should Attend? • Hematologists/oncologists/Hematopathologists • PG's : Internal Medicine/Pediatrics/Pathology/Basic Scientist with interest in hematological malignancies • Industry partners • Nurses and allied health professionals • Patient navigators and advocates

Who Should Attend? 
• Hematologists/oncologists/Hematopathologists
• PG's : Internal Medicine/Pediatrics/Pathology/Basic Scientist with interest in hematological malignancies
• Industry partners
• Nurses and allied health professionals
• Patient navigators and advocates
Mohammed Zubair (@zoo_bear) 's Twitter Profile Photo

The Election Commission today removed the digital machine-readable Bihar draft voter lists from its website which were uploaded on Aug 1. They have been replaced with their scanned, non-machine-readable versions that makes scrutiny harder. scroll.in/latest/1085399…

The Election Commission today removed the digital machine-readable Bihar draft voter lists from its website which were uploaded on Aug 1. They have been replaced with their scanned, non-machine-readable versions that makes scrutiny harder. 
scroll.in/latest/1085399…
Sanjay Jha (@jhasanjay) 's Twitter Profile Photo

Dear #ElectionCommission #RahulGandhi as Leader of Opposition has the support of 42% of INDIA Alliance voters. Mr Modi as Prime Minister has the backing of 44% of NDA voters. There is just a 2% difference, kindly note. The LoP deserves respect, not your contumacious

Vikram Mathews (@mathewsvikram) 's Twitter Profile Photo

PGCME registration is still open. Spot registration is also available, and a spill-over hall is available to accommodate additional attendees.

PGCME registration is still open. Spot registration is also available, and a spill-over hall is available to accommodate additional attendees.